Anti-Human MDC (CCL22) 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 500-P107 Descripcion Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hMDC (human Macrophage-Derived Chemokine). Anti-Human MDC specific antibody was purified by affinity chromatography employing immobilized hMDC matrix. Immunogen: E.coli derived Recombinant Human MDC (CCL22) (69 a.a.) (PeproTech catalog# 300-36A) Sandwich ELISA: To detect hMDC by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human MDC (500-P107Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hMDC. Western Blot: To detect hMDC by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hMDC is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Human, Mouse References SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest AIDS/HIV Chemotaxis Immune System Wound Healing product.subtitle.recentcitations Primer autor Rawal, S Titulo Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. Citar Journal of immunology (Baltimore, Md. : 1950); 190(12) pg6681-93 PudMed id 23686488 Primer autor Cocchi, F Titulo Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases. Citar Proceedings of the National Academy of Sciences of the United States of America; 109(14) pg5411-6 PudMed id 22431590 Primer autor Wågsäter, D Titulo Quantification of the chemokines CCL17 and CCL22 in human colorectal adenocarcinomas. Citar Molecular Medicine Reports; 1(2) pg211-7 PudMed id 21479399
